12 HR Treprostinil 2.5 MG Extended Release Oral Tablet

Known as: treprostinil 2.5 MG 12HR Extended Release Oral Tablet, TREPROSTINIL DIOLAMINE 2.5MG SA TAB, TREPROSTINIL DIOLAMINE 2.5MG TAB,SA [VA Product] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2015
01220132015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
INTRODUCTION Severe Raynaud's syndrome and DUs are the most prevalent manifestations of SSc peripheral microvascular disease. We… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Review
2015
Review
2015
Idiopathic pulmonary arterial hypertension (PAH) is a progressive disease without identifiable etiology and is characterized by… (More)
  • figure 1
  • table 1
Is this relevant?
2013
2013
INTRODUCTION Treprostinil diethanolamine is an innovative salt form of the prostacyclin analogue, treprostinil sodium, developed… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
BACKGROUND The Tyvaso Inhalation System is a hand-held nebulizer system used to administer treprostinil, an approved therapy for… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?